Literature Reviews

doi: 10.25005/2074-0581-2017-19-4-550-555
NEUROVEGETATIVE VIOLATIONS IN THE PATHOGENESIS OF VITILIGO

R.A. Rakhimov, K.M. Mukhamadieva, S.S. Ismatulloeva

Department of Dermatovenereology, Avicenna Tajik State Medical University, Dushanbe, Tajikistan

This article presents an analysis of contemporary publications dedicated to actuals of the role of neurovegetative disorders in the pathogenesis of vitiligo. Based on the generalized literary data, the authors focus on the relationship of vitiligo with disorders of various parts of the nervous system, leading to damage and degeneration of melanocytes. The chronic, progressive course of vitiligo, caused by the activity of the immune system and stimulated by neurovegetative dysbiosis, is directly related to the psychological reaction of the person for the presence of a cosmetic defect.

Keywords: Vitiligo, melanogenesis, autonomic nervous system, psychoemotional state.

Download file:


References
  1. Afsheen B, Irfan A. Guidelines for the management of vitiligo. Journal of Pakistan Association of Dermatologists. 2014;24(1):68-8.
  2. Taïeb A, Picardo M. Epidemiology, definitions and classification. In: Picardo M, Taïeb A, eds. Vitiligo, 1st edn. Berlin, Germany: Springer, 2010:13-24.
  3. Sharofutdinova LA, Lomonosov KM. K voprosu o klassifikatsii vitiligo [On the question of vitiligo classification]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2014;2:37-40.
  4. Belkheir NH, Duweb GH, El-Berghath A. Vitiligo: Epidemiology and manifestations. JEADV. 2008;37:281-8.
  5. Picardo M. Non-immunological mechanisms in the pathogenesis of vitiligo: An overview. JEADV. 2009;42:23-31.
  6. Rodrigue-Gervais IG, Saleh M. Genetics of inflammasome-associated disorders: a lesson in the guiding principles of inflammasome function. Eur J Immunol. 2010;40(3):643-88.
  7. Yang L, Wei Y, Sun Y, Shi W, Yang J, Zhu L, et al. Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo. Acta Derm Venereol. 2015; 95:664-70. Available from: http://dx.doi.org/10.2340/00015555-2080/j.jvs.2015.02. 27.
  8. Lomonosov KM, Simonova NI, Lomonosov MK. Sravnitel’nyy analiz syvorotochnogo soderzhaniya autoantitel u bol’nykh vitiligo [Comparative analysis of serum content of autoantibodies in vitiligo patients]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2013;2:35-9.
  9. Batpenova GR, Aymoldina AA, Kotlyarova TV, Tarkina TV, Sadykova DZ, Kazieva AC. Znachenie oksidativnogo stressa i immunologicheskikh rasstroystv pri vitiligo [The value of oxidative stress and immunological disorders in vitiligo]. Immunopatologiya, allergologiya, infektologiya. 2014;4:10-4.
  10. Arican O, Kurutas EB. Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatoven. 2008;17(1):12-5.
  11. Van Geel N, Mollet I, Brochez L, Dutre M, Schepper S De, Verhaeghe E, et al. New insights in segmental vitiligo: case report and review of theories. British Association of Dermatologists. 2012;166:240-6.
  12. Trapp EM, Trapp M, Sampogna F, Rohrer PM, Egger JW, Wolf P, et al. Autonomic nervous tone in vitiligo patients – A case-control study. Acta Dermato-Venereologica. 2015;95(2):169-72. Available from: http://dx.doi. org/10.2340/00015555-1896./j.jvs.2014.05.
  13. Binod K, Sushruta K, Ramam M. A descriptive study to characterize segmental vitiligo. Indian J Dermatol Venereol Leprology. 2012;6(78):715-21.
  14. Zoirov PT, Sobir SI. Osobennosti klicheskogo techeniya vitiligo s uchyotom tipa nervnoy sistemy [Features of the clinical course of vitiligo taking into account the type of nervous system]. Zdravookhranenie Tadzhikistana. 2010;4:54-7.
  15. Koshevenko YuN. Kozha cheloveka. Varianty patogennogo vozdeystviya na strukturu i funktsii kozhi, prichiny, patofiziologicheskie osnovy i printsipy lecheniya eyo bolezney. T. 2 [Human skin. Variants of pathogenic impact on the structure and functions of the skin, causes, pathophysiological foundations and principles of treatment of its diseases]. Moscow, RF: Meditsina; 2008. 754 p.
  16. Manolache L, Petrescu-Seceleanu D, Benea V. Correlation of stressful events with onset of vitiligo in children. J Eur Acad Dermatol Venereol. 2009; 23(2):187-8. Available from: http://dx.doi.org/10.1111/j.1468- 3083.2008.02764.x.
  17. Kossakowska MM, Ciescinska C, Jaszewska J, Placek WJ. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. JEADV. 2010;24(4):429-33.
  18. Usmanova AR, Fayzulina EV, Bunakova LK, Kuznetsova RG. Vliyanie urovnya stressa na kachestvo zhizni dermatovenerologicheskikh bol’nykh [The influence of stress level on quality of life of dermatological patients]. Aktual’nye problemy meditsiny. 2013;1(69):120-3.
  19. Elpem DJ. Toward a better understanding of «psychocutaneous disorders». Inter J Dermatol. 2009;48(12):1395-6.
  20. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206-12. Available from: http://dx.doi.org/10.1111/j.1365-4632.2011.05377.x.PMID 22458952.
  21. Talnikova EE, Svenskaya YuI, Dobdina AYu, Fatakhova KhV, Utz SR. Vitiligo: sovremennye metody terapii (obzor) [Vitiligo: modern methods of therapy (review)]. Saratovskiy nauchno-meditsinskiy zhurnal. 2017;13(3):668-73.
  22. Taïeb A, Picardo M. Vitiligo. N Engl J Med. 2009;360(2):160-9.
  23. Tamrazova OB, Gureeva MA. Patomimiya u detey. Vestnik dermatologii i venerologii. 2017;3:76-84.
  24. Yunusova EI, Yusupova LA, Garaeva ZSh, Mavlyutova GI. Osobennosti patogeneza i terapii bol’nykh vitiligo [Peculiarities of pathogenesis and therapy of vitiligo patients]. Lechashchiy vrach. 2017;11:24-5.
  25. El Din Zaki MS, Elbatrawy AN. Catecholamine level and its relation to anxiety and depression in patients with vitiligo. J Egypt Women Dermatol Soc. 2009;2(6):74-9.
  26. Ismaylov RG. Regulyatsiya melanogeneza pri dischromii kozhi [Regulation of melanogenesis in skin dyschromia]. Vestnik RAMN. 2014;1-2:85-92.
  27. Park JH, Jung MY, Lee JH, Yang JM, Lee DY, Park KK. Clinical course of segmental vitiligo: A retrospective study of eighty-seven patients. Ann Dermatol. 2014;1(26):61-5.
  28. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. J Am Acad Dermatol. 2011;65:473-91.
  29. Artykova TK, Ismailov KI. Perekisnoe okislenie lipidov i antioksidantnaya zashchita organizma u detey s vegeto-sosudistoy distoniey [Lipid peroxidation and antioxidant protection of the body in children with vegeto-vascular dystonia]. Vestnik Avitsenny [Avicenna Bulletin]. 2015;3:117-20.
  30. Zhavoronkova EV, Gornostaeva MA, Korsunskaya IM. Opyt primeneniya eltamina v terapii vitiligo [Experience of application stamina in the treatment of vitiligo]. Klinicheskaya dermatologiya i venerologiya. 2009;4:9-12.
  31. Gomes TR, Machado do NL; Tаvora M; Silva de C, Cesar С. Vitiligo – Part 1. An Bras Dermatol. 2017;89(3):461-70. Available from: http://dx.doi. org/10.1590/abd1806-4841.
  32. Malhotra N, Dytoc M. The pathogenesis of vitiligo. Journal of Cutaneous Medicine and Surgery. 2013;17(3):153-72.
  33. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work. J Dermatol. 2011;5(38):419-31.
  34. Attili VR, Attili SK. Segmental and generalized vitiligo: Both forms demonstrate inflammatory histopathological features and clinical mosaicism. Indian J Dermatol. 2013;58:433-8.
  35. Wu CS, Hu SC, Lan CC, Chen GS, Chuo WH, Yu HS. Low energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions. Kaohsiung J Med Sci. 2008;4(24):180-9. Available from: http://dx.doi.org/10.1016/ S1607-551X(08)70115-3.
  36. Zoirov PT, Sobir SI. Lechenie vitiligo s uchyotom tipa nervnoy sistemy. [Treatment of vitiligo taking into account the type of nervous system]. Zdravookhranenie Tadzhikistana. 2011;2:60-3.
  37. Artykov KP, Rakhmonov RA, Saveliev VA. Lekarstvennye preparaty, vliyayushchie na regeneratsiyu perifericheskikh nervov [Drugs affecting to the regeneration of peripheral nerves]. Vestnik Avitsenny [Avicenna Bulletin]. 2008;1:9-13.
  38. Geynits AV, Moskvin SV. Lazernaya terapiya v kosmetologii i dermatologii [Laser therapy in cosmetology and dermatology]. Tver, RF: Izdatel’stvo “Triada”; 2010. 400 p.
  39. Chapman BP, Moynihan J. The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol. 2009;6(5):623-7.

Authors informations:

Rakhimov Umed Saidmurtazoevich, Full-time Post-graduate Student in the Department of Dermatovenereology, Avicenna TSMU

Mukhamadieva Kibriyokhon Mansurovna, Doctor of Medical Sciences, Head of the Department of Dermatovenereology, Avicenna TSMU

Ismatulloeva Savrina Sadulloevna, Candidate of Medical Sciences, Assistant of the Department of Dermatovenereology, Avicenna TSMU

Address for correspondence:

Mukhamadieva Kibriyokhon Mansurovna
Doctor of Medical Sciences, Head of the Department of Dermatovenereology, Avicenna TSMU

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: (+992) 931 277575

E-mail: kibriyo_67@mail.ru